instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Rales'? | Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case report.
Severe acute respiratory syndrome coronavirus 2 disease is strongly associated with a high incidence of thrombotic events. Anticoagulation could be a cornerstone in successfully managing severe forms of coronavirus dis... | Recovering | ReactionOutcome | CC BY-NC | 34104863 | 19,494,069 | 2021-06 |
What was the outcome of reaction 'Septic shock'? | Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case report.
Severe acute respiratory syndrome coronavirus 2 disease is strongly associated with a high incidence of thrombotic events. Anticoagulation could be a cornerstone in successfully managing severe forms of coronavirus dis... | Fatal | ReactionOutcome | CC BY-NC | 34104863 | 19,494,069 | 2021-06 |
What was the outcome of reaction 'Traumatic lung injury'? | Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case report.
Severe acute respiratory syndrome coronavirus 2 disease is strongly associated with a high incidence of thrombotic events. Anticoagulation could be a cornerstone in successfully managing severe forms of coronavirus dis... | Recovering | ReactionOutcome | CC BY-NC | 34104863 | 19,495,913 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Congenital central nervous system anomaly'. | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | ALIROCUMAB, ALPRAZOLAM, ASPIRIN, EZETIMIBE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34105316 | 16,356,776 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | ALIROCUMAB, ALPRAZOLAM, ASPIRIN, EZETIMIBE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-ND | 34105316 | 16,356,776 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normal newborn'. | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | ALIROCUMAB, ANHYDROUS CITRIC ACID\DEXTROSE MONOHYDRATE\SODIUM CITRATE, ASPIRIN, CALCIUM, CLOPIDOGREL BISULFATE, EZETIMIBE, HEPARIN SODIUM, ROSUVASTATIN, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34105316 | 20,871,051 | 2021-09-01 |
What is the weight of the patient? | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | 3.22 kg. | Weight | CC BY-NC-ND | 34105316 | 16,356,776 | 2021-09-01 |
What was the administration route of drug 'ALPRAZOLAM'? | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 34105316 | 16,356,776 | 2021-09-01 |
What was the administration route of drug 'CLOPIDOGREL BISULFATE'? | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34105316 | 20,882,550 | 2021-09-01 |
What was the dosage of drug 'ANHYDROUS CITRIC ACID\DEXTROSE MONOHYDRATE\SODIUM CITRATE'? | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | 275 MILLILITER, PER SESSION | DrugDosageText | CC BY-NC-ND | 34105316 | 20,871,051 | 2021-09-01 |
What was the dosage of drug 'HEPARIN SODIUM'? | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | 1500 INTERNATIONAL UNIT | DrugDosageText | CC BY-NC-ND | 34105316 | 20,871,051 | 2021-09-01 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | UNK, INFUSION | DrugDosageText | CC BY-NC-ND | 34105316 | 20,871,051 | 2021-09-01 |
What was the outcome of reaction 'Congenital central nervous system anomaly'? | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34105316 | 16,356,776 | 2021-09-01 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Exposure to alirocumab during the first trimester of pregnancy: A case report.
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful pla... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34105316 | 16,356,776 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Microcephaly'. | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | CYCLOPHOSPHAMIDE, DOCETAXEL, DOXORUBICIN HYDROCHLORIDE, TAMOXIFEN, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 34106263 | 20,096,079 | 2021-06-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Phalangeal hypoplasia'. | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | CYCLOPHOSPHAMIDE, DOCETAXEL, DOXORUBICIN HYDROCHLORIDE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS | DrugsGivenReaction | CC BY | 34106263 | 19,932,084 | 2021-06-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Syndactyly'. | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | CYCLOPHOSPHAMIDE, DOCETAXEL, DOXORUBICIN HYDROCHLORIDE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS | DrugsGivenReaction | CC BY | 34106263 | 19,932,084 | 2021-06-01 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | Transplacental | DrugAdministrationRoute | CC BY | 34106263 | 19,932,084 | 2021-06-01 |
What was the administration route of drug 'DOCETAXEL'? | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | Transplacental | DrugAdministrationRoute | CC BY | 34106263 | 19,932,084 | 2021-06-01 |
What was the administration route of drug 'DOXORUBICIN HYDROCHLORIDE'? | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | Transplacental | DrugAdministrationRoute | CC BY | 34106263 | 19,932,084 | 2021-06-01 |
What was the administration route of drug 'GRANULOCYTE COLONY-STIMULATING FACTOR NOS'? | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | Transplacental | DrugAdministrationRoute | CC BY | 34106263 | 19,932,084 | 2021-06-01 |
What was the administration route of drug 'TAMOXIFEN'? | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | Transplacental | DrugAdministrationRoute | CC BY | 34106263 | 19,911,157 | 2021-06-01 |
What was the administration route of drug 'TEMOZOLOMIDE'? | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | Transplacental | DrugAdministrationRoute | CC BY | 34106263 | 20,096,079 | 2021-06-01 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.
Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear.
To assess congenital mal... | Recovered | ReactionOutcome | CC BY | 34106263 | 19,932,084 | 2021-06-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia: A case report.
BACKGROUND
Significant concerns about the adverse effects following chimeric antigen receptor T cell (CAR-T) therapy are still remaine... | METHYLPREDNISOLONE, RUXOLITINIB, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34106613 | 19,461,437 | 2021-05-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytokine release syndrome'. | Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia: A case report.
BACKGROUND
Significant concerns about the adverse effects following chimeric antigen receptor T cell (CAR-T) therapy are still remaine... | METHYLPREDNISOLONE, RUXOLITINIB, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34106613 | 19,461,437 | 2021-05-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia: A case report.
BACKGROUND
Significant concerns about the adverse effects following chimeric antigen receptor T cell (CAR-T) therapy are still remaine... | METHYLPREDNISOLONE, RUXOLITINIB, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34106613 | 19,461,437 | 2021-05-14 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia: A case report.
BACKGROUND
Significant concerns about the adverse effects following chimeric antigen receptor T cell (CAR-T) therapy are still remaine... | 40 mg (milligrams). | DrugDosage | CC BY | 34106613 | 19,461,437 | 2021-05-14 |
What was the dosage of drug 'TOCILIZUMAB'? | Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia: A case report.
BACKGROUND
Significant concerns about the adverse effects following chimeric antigen receptor T cell (CAR-T) therapy are still remaine... | 400 mg (milligrams). | DrugDosage | CC BY | 34106613 | 19,461,437 | 2021-05-14 |
What was the outcome of reaction 'Cytokine release syndrome'? | Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia: A case report.
BACKGROUND
Significant concerns about the adverse effects following chimeric antigen receptor T cell (CAR-T) therapy are still remaine... | Recovered | ReactionOutcome | CC BY | 34106613 | 19,461,437 | 2021-05-14 |
What was the administration route of drug 'PROPOFOL'? | Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report.
BACKGROUND
Malignant catatonia (MC) is a movement disorder syndrome characterized by immobility, rigidity, and consciousness disorders that develops in association with mental and phys... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34106671 | 20,650,854 | 2021-05-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.
Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations.
We report a case of spontaneous peri... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, HEPARIN SODIUM, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34107924 | 20,481,432 | 2021-06-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.
Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations.
We report a case of spontaneous peri... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, HEPARIN SODIUM, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34107924 | 20,481,432 | 2021-06-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal haemorrhage'. | Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.
Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations.
We report a case of spontaneous peri... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, HEPARIN SODIUM, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34107924 | 20,481,432 | 2021-06-09 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.
Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations.
We report a case of spontaneous peri... | Intravenous bolus | DrugAdministrationRoute | CC BY | 34107924 | 20,481,432 | 2021-06-09 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.
Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations.
We report a case of spontaneous peri... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34107924 | 20,481,432 | 2021-06-09 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.
Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations.
We report a case of spontaneous peri... | TWO BOLUSES | DrugDosageText | CC BY | 34107924 | 20,481,432 | 2021-06-09 |
What was the dosage of drug 'CYCLOSPORINE'? | Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.
Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations.
We report a case of spontaneous peri... | 50 mg (milligrams). | DrugDosage | CC BY | 34107924 | 20,481,432 | 2021-06-09 |
What was the outcome of reaction 'Renal haemorrhage'? | Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.
Spontaneous perirenal hemorrhage is relatively uncommon but may be life-threatening. There are some challenges in early diagnosis due to the lack of specific presentations.
We report a case of spontaneous peri... | Recovered | ReactionOutcome | CC BY | 34107924 | 20,481,432 | 2021-06-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | DULAGLUTIDE, FENOFIBRATE, GLIMEPIRIDE, ROSUVASTATIN, TAMOXIFEN, TOCOPHERYL NICOTINATE, D-.ALPHA. | DrugsGivenReaction | CC BY | 34107939 | 19,570,772 | 2021-06-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dehydration'. | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | ROSUVASTATIN, TAMOXIFEN, TOCOPHEROL | DrugsGivenReaction | CC BY | 34107939 | 19,497,251 | 2021-06-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis acute'. | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | DULAGLUTIDE, FENOFIBRATE, GLIMEPIRIDE, ROSUVASTATIN, TAMOXIFEN, TOCOPHERYL NICOTINATE, D-.ALPHA. | DrugsGivenReaction | CC BY | 34107939 | 19,570,772 | 2021-06-09 |
What is the weight of the patient? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | 52 kg. | Weight | CC BY | 34107939 | 19,500,377 | 2021-06-09 |
What was the administration route of drug 'ROSUVASTATIN CALCIUM'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | Oral | DrugAdministrationRoute | CC BY | 34107939 | 19,500,377 | 2021-06-09 |
What was the administration route of drug 'TAMOXIFEN CITRATE'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | Oral | DrugAdministrationRoute | CC BY | 34107939 | 19,500,377 | 2021-06-09 |
What was the administration route of drug 'TOCOPHERYL NICOTINATE, D-.ALPHA.'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | Oral | DrugAdministrationRoute | CC BY | 34107939 | 19,500,377 | 2021-06-09 |
What was the dosage of drug 'FENOFIBRATE'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | 80 mg (milligrams). | DrugDosage | CC BY | 34107939 | 19,570,772 | 2021-06-09 |
What was the dosage of drug 'INSULIN NOS'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | DOSE UNKNOWN | DrugDosageText | CC BY | 34107939 | 19,500,377 | 2021-06-09 |
What was the dosage of drug 'ROSUVASTATIN'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | 2.5 mg (milligrams). | DrugDosage | CC BY | 34107939 | 19,570,772 | 2021-06-09 |
What was the dosage of drug 'TAMOXIFEN CITRATE'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | DOSE UNKNOWN | DrugDosageText | CC BY | 34107939 | 19,500,377 | 2021-06-09 |
What was the dosage of drug 'TOCOPHEROL'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | 400 mg (milligrams). | DrugDosage | CC BY | 34107939 | 19,497,251 | 2021-06-09 |
What was the outcome of reaction 'Condition aggravated'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | Recovering | ReactionOutcome | CC BY | 34107939 | 19,570,772 | 2021-06-09 |
What was the outcome of reaction 'Dehydration'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | Recovering | ReactionOutcome | CC BY | 34107939 | 19,497,251 | 2021-06-09 |
What was the outcome of reaction 'Hypertriglyceridaemia'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | Recovering | ReactionOutcome | CC BY | 34107939 | 19,500,377 | 2021-06-09 |
What was the outcome of reaction 'Pancreatitis acute'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | Recovering | ReactionOutcome | CC BY | 34107939 | 19,570,772 | 2021-06-09 |
What was the outcome of reaction 'Renal impairment'? | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time.
BACKGROUND
Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We... | Recovering | ReactionOutcome | CC BY | 34107939 | 19,500,377 | 2021-06-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation.
We report on a case of metastatic urothelial bladder carcinoma (mUBC) treated with anlotinib combined with sintilimab. A 69-year-old male was diagnosed with non-muscle invasi... | CISPLATIN, GEMCITABINE | DrugsGivenReaction | CC BY | 34109111 | 20,557,200 | 2021 |
What was the administration route of drug 'GEMCITABINE'? | Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation.
We report on a case of metastatic urothelial bladder carcinoma (mUBC) treated with anlotinib combined with sintilimab. A 69-year-old male was diagnosed with non-muscle invasi... | Intravesical | DrugAdministrationRoute | CC BY | 34109111 | 20,557,200 | 2021 |
What was the dosage of drug 'CISPLATIN'? | Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation.
We report on a case of metastatic urothelial bladder carcinoma (mUBC) treated with anlotinib combined with sintilimab. A 69-year-old male was diagnosed with non-muscle invasi... | 4 CYCLES | DrugDosageText | CC BY | 34109111 | 20,557,200 | 2021 |
What was the dosage of drug 'GEMCITABINE'? | Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation.
We report on a case of metastatic urothelial bladder carcinoma (mUBC) treated with anlotinib combined with sintilimab. A 69-year-old male was diagnosed with non-muscle invasi... | SINGLE-DOSE 4 CYCLES | DrugDosageText | CC BY | 34109111 | 20,557,200 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Gastric Adenocarcinoma Presenting as a Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibody-Positive Polyarthritis: A Case Report and Review of Literature.
A 64-year-old male presented with a 6-month history of symmetric polyarthritis involving proximal interphalangeal joints and metacarpophalangeal joints ... | ACETAMINOPHEN, CISPLATIN, FLUOROURACIL, HYDROXYCHLOROQUINE, PREDNISOLONE, TRAMADOL, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34109188 | 20,127,473 | 2021 |
What was the outcome of reaction 'Adenocarcinoma gastric'? | Gastric Adenocarcinoma Presenting as a Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibody-Positive Polyarthritis: A Case Report and Review of Literature.
A 64-year-old male presented with a 6-month history of symmetric polyarthritis involving proximal interphalangeal joints and metacarpophalangeal joints ... | Fatal | ReactionOutcome | CC BY | 34109188 | 20,017,142 | 2021 |
What was the outcome of reaction 'Death'? | Gastric Adenocarcinoma Presenting as a Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibody-Positive Polyarthritis: A Case Report and Review of Literature.
A 64-year-old male presented with a 6-month history of symmetric polyarthritis involving proximal interphalangeal joints and metacarpophalangeal joints ... | Fatal | ReactionOutcome | CC BY | 34109188 | 20,017,142 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | AMOXICILLIN\CLAVULANIC ACID, OSELTAMIVIR | DrugsGivenReaction | CC BY-NC | 34109292 | 20,205,806 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | AMOXICILLIN\CLAVULANIC ACID, OSELTAMIVIR | DrugsGivenReaction | CC BY-NC | 34109292 | 20,205,806 | 2021-05 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANATE POTASSIUM'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34109292 | 20,269,599 | 2021-05 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34109292 | 20,161,942 | 2021-05 |
What was the administration route of drug 'BOSENTAN'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | Oral | DrugAdministrationRoute | CC BY-NC | 34109292 | 20,074,085 | 2021-05 |
What was the administration route of drug 'OSELTAMIVIR'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34109292 | 20,269,599 | 2021-05 |
What was the administration route of drug 'SELEXIPAG'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | Oral | DrugAdministrationRoute | CC BY-NC | 34109292 | 20,074,085 | 2021-05 |
What was the dosage of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | MATERNAL DOSE: UNK (STARTED IN FEB 2018) | DrugDosageText | CC BY-NC | 34109292 | 20,161,942 | 2021-05 |
What was the dosage of drug 'OSELTAMIVIR'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | MATERNAL DOSE: UNK (STARTED IN FEB 2018) | DrugDosageText | CC BY-NC | 34109292 | 20,161,942 | 2021-05 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | Recovered | ReactionOutcome | CC BY-NC | 34109292 | 20,074,085 | 2021-05 |
What was the outcome of reaction 'Premature delivery'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | Recovered | ReactionOutcome | CC BY-NC | 34109292 | 20,074,085 | 2021-05 |
What was the outcome of reaction 'Pulmonary arterial hypertension'? | Pulmonary arterial hypertension unveils itself: a cancer-like progression - a case report.
Pulmonary arterial hypertension (PAH) is a rare disorder with a poor prognosis, characterized by progressive remodelling of the small pulmonary arteries that precede the clinical and haemodynamic manifestations of the disease. Th... | Recovering | ReactionOutcome | CC BY-NC | 34109292 | 19,740,929 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | PAMIDRONATE DISODIUM | DrugsGivenReaction | CC BY-NC-ND | 34110303 | 19,885,031 | 2021-06-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | AMPHOTERICIN B, ASPIRIN, CHOLECALCIFEROL, CYCLOSPORINE, ENTECAVIR, FLUCONAZOLE, FLUCYTOSINE, INSULIN NOS, MYCOPHENOLATE MOFETIL, PAMIDRONATE DISODIUM, PREGABALIN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC-ND | 34110303 | 19,867,425 | 2021-06-01 |
What was the administration route of drug 'AMPHOTERICIN B'? | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34110303 | 19,867,425 | 2021-06-01 |
What was the administration route of drug 'FLUCONAZOLE'? | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34110303 | 19,867,425 | 2021-06-01 |
What was the administration route of drug 'FLUCYTOSINE'? | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34110303 | 19,867,425 | 2021-06-01 |
What was the administration route of drug 'PAMIDRONATE DISODIUM'? | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34110303 | 19,867,425 | 2021-06-01 |
What was the dosage of drug 'MYCOPHENOLIC ACID'? | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | 1000 MG | DrugDosageText | CC BY-NC-ND | 34110303 | 20,213,806 | 2021-06-01 |
What was the outcome of reaction 'Cryptococcosis'? | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34110303 | 20,213,806 | 2021-06-01 |
What was the outcome of reaction 'Disseminated cryptococcosis'? | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34110303 | 20,213,806 | 2021-06-01 |
What was the outcome of reaction 'Hypercalcaemia'? | Refractory hypercalcaemia associated with disseminated Cryptococcus neoformans infection.
Hypercalcaemia is a very common endocrine condition, yet severe hypercalcaemia as a result of fungal infection is rarely described. There are have only been two reported cases in the literature of hypercalcaemia associated with Cr... | Recovered | ReactionOutcome | CC BY-NC-ND | 34110303 | 20,213,806 | 2021-06-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cataract'. | Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
OBJECTIVE
To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.
METHODS
Retrospective, multicen... | AFLIBERCEPT, BEVACIZUMAB, RANIBIZUMAB | DrugsGivenReaction | CC BY | 34110547 | 19,949,957 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endophthalmitis'. | Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
OBJECTIVE
To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.
METHODS
Retrospective, multicen... | AFLIBERCEPT, BEVACIZUMAB, RANIBIZUMAB | DrugsGivenReaction | CC BY | 34110547 | 19,949,957 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intraocular pressure increased'. | Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
OBJECTIVE
To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.
METHODS
Retrospective, multicen... | AFLIBERCEPT, BEVACIZUMAB, RANIBIZUMAB | DrugsGivenReaction | CC BY | 34110547 | 19,949,957 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
OBJECTIVE
To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.
METHODS
Retrospective, multicen... | AFLIBERCEPT, BEVACIZUMAB, RANIBIZUMAB | DrugsGivenReaction | CC BY | 34110547 | 19,949,957 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retinal detachment'. | Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
OBJECTIVE
To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.
METHODS
Retrospective, multicen... | AFLIBERCEPT, BEVACIZUMAB, RANIBIZUMAB | DrugsGivenReaction | CC BY | 34110547 | 19,949,957 | 2021-10 |
What was the administration route of drug 'AFLIBERCEPT'? | Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
OBJECTIVE
To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.
METHODS
Retrospective, multicen... | Other | DrugAdministrationRoute | CC BY | 34110547 | 19,949,957 | 2021-10 |
What was the administration route of drug 'BEVACIZUMAB'? | Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
OBJECTIVE
To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.
METHODS
Retrospective, multicen... | Other | DrugAdministrationRoute | CC BY | 34110547 | 19,949,957 | 2021-10 |
What was the administration route of drug 'RANIBIZUMAB'? | Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.
OBJECTIVE
To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.
METHODS
Retrospective, multicen... | Other | DrugAdministrationRoute | CC BY | 34110547 | 19,949,957 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coagulopathy'. | Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
We intended to investigate the clinical features of paediatric patients with chronic active Epstein-Barr virus infection (CAEBV) and to examine the effectiveness of the L-DEP regimen before haematopoietic stem cell transpla... | DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, METHYLPREDNISOLONE, PEGASPARGASE | DrugsGivenReaction | CC BY | 34112210 | 19,533,507 | 2021-06-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
We intended to investigate the clinical features of paediatric patients with chronic active Epstein-Barr virus infection (CAEBV) and to examine the effectiveness of the L-DEP regimen before haematopoietic stem cell transpla... | DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, METHYLPREDNISOLONE, PEGASPARGASE | DrugsGivenReaction | CC BY | 34112210 | 19,533,507 | 2021-06-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
We intended to investigate the clinical features of paediatric patients with chronic active Epstein-Barr virus infection (CAEBV) and to examine the effectiveness of the L-DEP regimen before haematopoietic stem cell transpla... | DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, METHYLPREDNISOLONE, PEGASPARGASE | DrugsGivenReaction | CC BY | 34112210 | 19,533,507 | 2021-06-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
We intended to investigate the clinical features of paediatric patients with chronic active Epstein-Barr virus infection (CAEBV) and to examine the effectiveness of the L-DEP regimen before haematopoietic stem cell transpla... | DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, METHYLPREDNISOLONE, PEGASPARGASE | DrugsGivenReaction | CC BY | 34112210 | 19,533,510 | 2021-06-10 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
We intended to investigate the clinical features of paediatric patients with chronic active Epstein-Barr virus infection (CAEBV) and to examine the effectiveness of the L-DEP regimen before haematopoietic stem cell transpla... | 25 MG/M2, ON DAY 1, CYCLIC | DrugDosageText | CC BY | 34112210 | 19,533,507 | 2021-06-10 |
What was the dosage of drug 'ETOPOSIDE'? | Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
We intended to investigate the clinical features of paediatric patients with chronic active Epstein-Barr virus infection (CAEBV) and to examine the effectiveness of the L-DEP regimen before haematopoietic stem cell transpla... | 100 MG/M2, DAYS 1, 8 AND 15, ONCE A WEEK CYCLIC | DrugDosageText | CC BY | 34112210 | 19,533,507 | 2021-06-10 |
What was the outcome of reaction 'Coagulopathy'? | Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
We intended to investigate the clinical features of paediatric patients with chronic active Epstein-Barr virus infection (CAEBV) and to examine the effectiveness of the L-DEP regimen before haematopoietic stem cell transpla... | Not recovered | ReactionOutcome | CC BY | 34112210 | 19,533,507 | 2021-06-10 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.